Storia in 1 fonti

Exclusive: Genetic medicine startup launches to speed programs that stalled at Editas, Biogen

Lyora Therapeutics launches with $2.5M in pre-seed funding to revive stalled eye gene therapy programs from Editas and Biogen, targeting a first IND within 18 months.

Raccontata da

endpoints.news

Timeline cronologica

martedì 14 luglio 2026·endpoints.news
Exclusive: Genetic medicine startup launches to speed programs that stalled at Editas, Biogen
Lyora Therapeutics launches with $2.5M in pre-seed funding to revive stalled eye gene therapy programs from Editas and Biogen, targeting a first IND within 18 months.